<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02773433</url>
  </required_header>
  <id_info>
    <org_study_id>14.1009</org_study_id>
    <nct_id>NCT02773433</nct_id>
  </id_info>
  <brief_title>PAV vs Assist Control After Failed SBT</brief_title>
  <official_title>Proportional Assist Ventilation Versus Volume-Assist-Control After a Failed Spontaneous Breathing Trial: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this research is to determine the feasibility of conducting a randomized&#xD;
      controlled trial comparing two ventilation modes in patients admitted to the ICU who require&#xD;
      mechanical ventilation. The investigators plan to include patients on mechanical ventilation&#xD;
      with low support (PaO2/FiO2 ratio &gt; 200, FiO2 &lt; 0.5 and PEEP &lt; 8) for a period no longer than&#xD;
      48 hrs. There are a number of potential barriers to enroll patients in the study. Importantly&#xD;
      patients will have to be enrolled within 48 hours from the time they meet inclusion criteria.&#xD;
&#xD;
      The secondary aims are to determine the impact of proportional assist-ventilation (PAV)&#xD;
      versus volume assist-control (VAC) ventilation by evaluating the number of ventilation-free&#xD;
      days, development of Intensive Care Unit (ICU) delirium, use of sedative/ analgesic&#xD;
      medications, use of antipsychotic medications, length of stay in the intensive care unit and&#xD;
      hospital, reintubations within 24 hours, adverse events, and mortality in the two groups of&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overview of Design Randomized controlled pilot study comparing mechanical ventilation modes&#xD;
      and daily spontaneous trial combination, in patients requiring invasive mechanical&#xD;
      ventilation with low ventilator support (PaO2/Fio2 ratio &gt; 200, FiO2 &lt; 0.5 &amp; PEEP &lt;8) for a&#xD;
      period not greater than 48 hrs.&#xD;
&#xD;
      Hypothesis The investigators hypothesize that 50 % of patients approached will agree to&#xD;
      enrollment in this clinical trial over a period of 4 months. The investigators hypothesize&#xD;
      80% of the patients meeting inclusion criteria will be approached in a timely manner. The&#xD;
      investigators also propose that PAV mode ventilation will be superior to ACV based on&#xD;
      clinical outcome measurements.&#xD;
&#xD;
      Study Subjects Consecutive adult patients requiring invasive mechanical ventilation on low&#xD;
      ventilator support (as mentioned above) for a period not greater than 48 hrs will be enrolled&#xD;
      if they or their proxy consent for the study. The study will be performed in the intensive&#xD;
      care units of University of Louisville and Jewish Hospital in Louisville, KY.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of patients who meet criteria for enrollment who are approached in a timely manner</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>patient enrollment number over time</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>compliance with the ventilator settings</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventilation free days from the time patient is enrolled in the study</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of ICU delirium Based on CAM ICU</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of sedative or analgesic medications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of antipsychotic medications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reintubations within 24 hrs</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the intensive care unit</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the hospital</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In hospital mortality</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Weaning Mode Comparison</condition>
  <arm_group>
    <arm_group_label>PAV group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using Proportional Assist Ventilation after failed Spontaneous Breathing Trial</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Using Volume Assist Control mode after failed SBT</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Proportional Assist Ventilation</intervention_name>
    <arm_group_label>PAV group</arm_group_label>
    <other_name>PAV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt;18 yrs old&#xD;
&#xD;
          2. Patient or proxy available in the hospital to consent&#xD;
&#xD;
          3. Receipt of invasive mechanical ventilation on low ventilator support (Po2/Fio2 ratio&#xD;
             &gt;200, Fio2 &lt;60% &amp; PEEP &lt;8) for a period not greater than 48 hrs&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant patients&#xD;
&#xD;
          2. Terminal diseases (e.g. advanced or metastatic malignancy, liver cirrhosis with an&#xD;
             estimated 3 month mortality &gt; 50%)&#xD;
&#xD;
          3. Severely depressed respiratory drive&#xD;
&#xD;
          4. Receipt of neuromuscular blocker&#xD;
&#xD;
          5. Bronchopleural fistula&#xD;
&#xD;
          6. Inability to obtain consent from patients or their proxies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodrigo Cavallazzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UofLouisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>May 12, 2016</study_first_submitted>
  <study_first_submitted_qc>May 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2016</study_first_posted>
  <last_update_submitted>December 5, 2016</last_update_submitted>
  <last_update_submitted_qc>December 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Rodrigo Cavallazzi</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

